Research

With major research, legal reform, and more than 20 firms going public, it was major year for the re-emerging field

From CBD drivers to stoner rats, legal reform continues to push weed research to an all-time high

Brock University's Michael Armstrong argues Canada's restrictive labelling rules incentivize producers to maximize THC content and minimize price

Through its university partnership, the firm wants to attract big pharma backers by making 100,000s of novel psychedelic derivatives for new precision medicine

A first-of-its-kind clinical trial shows a dramatic drop in depression in over half of patients who received a synthetic version of the compound

Lead researcher and Tilray VP Philippe Lucas says new data shows why Canada regulating weed on par with alcohol would reduce societal harms

A recent questionnaire highlights how a taxed system with strictly commercial access leaves patients treating themselves outside official channels

The data firm says it aims to re-establish access to supply chain information cut off by government distributors, empowering producers and retailers

Following the OCS's release of its first-quarter report this week, attorney Trina Fraser questions the ongoing lack of transparency

Figures from 2019 vary significantly with previous news reports, which could land Health Canada in hot water if it can't explain why

Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can

Results should be used by policy makers to save lives during the overdose crisis, says cannabis and addiction scientist M-J Milloy

A detailed look at non-prescription cannabidiol in 9 countries reveals a regulatory hodgepodge outpaced by a wild west market

Projections from industry analysts, conflicting data and expert opinion call StatsCan's survey-based figures into question

Avail Cannabis clinic will monitor 30 veterans from Ont. or Man. for 3 months to see if symptoms improve

Director and producer David Jakubovic says stigma can be broken with just 5 minutes of being open to science

Data suggest gummies are primed to increase sales share and there's opportunity for new brands to enter the space

The trend emphasizes the need for online product info, which can cause a consumer to jump if not available, says branding expert

A recent review found use could negatively impact heart health, but laws impeding research means there's a lack of hard evidence

Authors of the rare qualitative research say health services must incorporate evidence that cannabis can reduce more harmful substance use

Vermont cannabis lawyer Timothy Fair calls FDA's two-year delay on CBD regulations 'beyond absurd'

General Covid-related spending habits appear to be responsible for the trend

Biosynthetic cannabinoids use a fraction of extraction's cost, energy, water and biomass waste

Complaints of inadequate regulatory framework and prohibitive cost mirror criticisms in Canada

Extracting psilocybin from magic mushrooms will be cheaper than current method of creating synthetic compound for research, says company

The bulk value category is trending up as legal players compete with Canada's still-thriving unregulated market

Cannabis is legal in Canada, but four main barriers block marginalized people from accessing the regulated market

A new study from researchers in New Zealand suggests even mild smoking habits can cause the illness

Male offspring are less vulnerable to cannabinoid exposure, but researchers aren't sure why

Not only is terpene information a cost-effective way to empower consumers, but it could play an important role in tracking Canada's sought-after genetics

Studies on the potential harms of weed use are often written off as propaganda, but dismissing research can be harmful in its own right

But during COVID-19, other data show an ensuing sales surge and a 4/20 boost

The report used the stoner holiday to show how black people are still almost 4X more likely to be arrested for weed

Medical and therapeutic benefits are clear even if scalability isn't

Cannabis sales are on pace for US$745 million in 2020, which could be a catalyst for legalization in neighbouring states, says BDS Analytics

A new self-administration research model opens doors to fascinating questions that can't be explored in studies on people

The recent COVID-19-related sales bump won't last as demand for cannabis isn't as inelastic during a recession as some think, Jerome Hass of Lightwater Partners says

BDS Analytics’s CEO weighs in on the most recent round of sales data from one of the industry’s leading data firms

Study found 61 per cent of participants felt a psychedelic-like high after taking placebo pill

As misinformation spreads like a virus, Cannalogue wants to conduct research to see if CBD can be used to fight the pandemic